Dror Mevorach
Founder chez ENLIVEX THERAPEUTICS LTD.
Fortune : 889 350 $ au 31/03/2024
Provenance du réseau au premier degré de Dror Mevorach
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 19 | |
Hadassah University Hospital
 Hadassah University Hospital Hospital/Nursing ManagementHealth Services Hadassah University Hospital engages in the operation of hospitals and medical centers in Israel and abroad. Its services include hospitalization services, medical services, medical tourism, and research and development. The company was founded in 1934 and is headquartered in Jerusalem, Israel.
9
| Subsidiary | Hospital/Nursing Management | 9 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Dror Mevorach via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Thomas Jefferson University | College/University | Corporate Officer/Principal | |
| MOLECULAR PHARMACOLOGY (USA), LTD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Janssen R&D Ireland Ltd. | President | ||
OPKO Biologics Ltd.
 OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Pharmaceuticals: Major | Founder Chief Executive Officer Chief Executive Officer Director/Board Member | |
| DARIOHEALTH CORP. | Medical Specialties | Director/Board Member | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree | |
| Ben-Gurion University of the Negev | College/University | Graduate Degree Doctorate Degree | |
| Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Hadasit Medical Research Services & Development Ltd.
 Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| OPKO HEALTH, INC. | Medical/Nursing Services | Corporate Officer/Principal | |
| Sidney Kimmel Medical College | College/University | Corporate Officer/Principal | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Institute of Human Virology
 Institute of Human Virology Other Consumer ServicesConsumer Services The Institute of Human Virology (IHV) is a research institute located in Baltimore, MD, affiliated with the University of Maryland School of Medicine. The IHV is the first research institute in the US to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments for chronic viral diseases such as HIV/AIDS, hepatitis C, hepatitis B, and human papillomavirus infection. The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV also provides compassionate cutting-edge care and specializes in the treatment of HIV/AIDS and other chronic viral diseases. | Other Consumer Services | Chairman | |
| HBL - HADASIT BIO-HOLDINGS LTD | Investment Managers | Chief Executive Officer Director/Board Member | |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| CONTRAFECT CORPORATION | Biotechnology | Chief Executive Officer | |
| Johnson & Johnson Pharmaceutical Group | Corporate Officer/Principal | ||
| ERECH FINANCE CAHALACHA LTD | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Tibotec Pharmaceuticals | Chief Executive Officer | ||
| Israel Ministry of Health | General Government | Corporate Officer/Principal | |
| The College of Management Academic Studies | College/University | Masters Business Admin | |
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
Celleron Therapeutics Ltd.
 Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Pharmaceuticals: Major | Director/Board Member | |
D-Cure
 D-Cure Hospital/Nursing ManagementHealth Services D-Cure provides treatments for diabetes. The non-profit company is based in Jerusalem, Israel. The Israeli company was founded by Shilo Ben-Zeev. | Hospital/Nursing Management | President | |
| The Hebrew University Hadassah Medical School | College/University | Doctorate Degree Doctorate Degree | |
Nuriel & Sons Transport Ltd.
 Nuriel & Sons Transport Ltd. Air Freight/CouriersTransportation Nuriel & Sons Transport Ltd. provides transportation services. The private company is based in Herzliya, Israel. The CEO of the Israeli company is Oren Levy. | Air Freight/Couriers | Chief Executive Officer | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member | |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Consultant / Advisor Human Resources Officer | |
| Solangia Ltd. | Director/Board Member | ||
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Chairman | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chairman | |
| Janssen Therapeutics, Inc. | President | ||
Prolor Biotech Ltd.
 Prolor Biotech Ltd. BiotechnologyHealth Technology Prolor Biotech Ltd. develops proprietary versions of already-approved therapeutic proteins. The private company is based in Nes Ziona, Israel. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO | |
| Pomerantz Life Sciences Consulting Group LLC | President | ||
| Fritz Cos. Israel T. Ltd. | Director/Board Member | ||
| VIRACTA THERAPEUTICS, INC. | Biotechnology | Chairman | |
| INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| Technion Institute | College/University | Undergraduate Degree |
Statistiques
Internationale
| Israël | 23 |
| Etats-Unis | 21 |
| Irlande | 3 |
| Royaume-Uni | 2 |
| Chypre | 2 |
Sectorielle
| Health Technology | 21 |
| Consumer Services | 11 |
| Health Services | 4 |
| Finance | 4 |
| Commercial Services | 3 |
Opérationnelle
| Director/Board Member | 103 |
| Corporate Officer/Principal | 33 |
| Chairman | 26 |
| Independent Dir/Board Member | 25 |
| Chief Executive Officer | 16 |
Relations les plus connectées
| Insiders | |
|---|---|
| Roger Pomerantz | 30 |
| Michel Moise Habib | 23 |
| Chezy Ofir | 19 |
| Bernhard Kirschbaum | 15 |
| Avri Havron | 14 |
| Shai Novik | 13 |
| Sangwoo Lee | 12 |
| Samer Haj Yehia | 11 |
| Gili Hart | 11 |
| Brian Schwartz | 9 |
| Oren Levy | 8 |
| Andrew Singer | 7 |
| Oren Elmaliah | 6 |
| Dana Wolf | 6 |
| Itamar Raz | 6 |
- Bourse
- Insiders
- Dror Mevorach
- Connexions Sociétés
